Longevity Biotech is developing a new class of therapeutic candidates called Hybridtides®. Our focus is on delivering clinically transformative products that tackle the most challenging aspects of medicine today. The unique Hybridtide® scaffold provides critical enhancements over previous peptide development efforts.

Longevity Biotech is a peptide therapeutics firm with capabilities in production, purification, stability profiling, formulation, bioanalytics, absorption and in vivo PK analysis.